Clinical Trials in Baltimore

Showing 7461-7480 of 23,476 trials

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

NCT02561455

The purpose of the study was to provide access to continued treatment for those who participated in other Astellas sponsored ASP2215 trials that completed the primary analysis and, had the potential to continue to derive clinical benefit from the treatment with ASP2215, and who did not meet any of the study discontinuation criteria in the present study.

Advanced Solid TumorsAcute Myeloid Leukemia

Astellas Pharma Global Development, Inc.9 participantsStarted May 2016

Phoenix, Arizona, United States • Baltimore, Maryland, United States • New York, New York, United States +4 more locations

COMPLETEDPhase 1/2< 1 mile

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

NCT02614066

The primary objectives of this study are to determine the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in adult participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL).

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Kite, A Gilead Company125 participantsStarted Mar 2016

La Jolla, California, United States • Los Angeles, California, United States • Orange, California, United States +30 more locations

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Find Trials by Condition in Baltimore

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Dopamine and Motor Learning in Cerebral Palsy

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Extravascular ICD Pivotal Study

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Pediatric Cardiac Output Monitoring Observational Study

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Pediatric Adenotonsillectomy Trial for Snoring

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors